Koninklijke Philips NV vs Target Corporation — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while Target Corporation trades at $138.07 (market cap $63.40B). The key difference: Target Corporation is far larger — about 2.4× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| PHG | TGT | |
|---|---|---|
Market Cap | $25.89B | $63.40B |
Sector | Health | Consumer Cyclical |
52-Week High | $32.91 | $141.19 |
52-Week Low | $25.02 | $83.68 |
Enterprise Value | $32.18B | $78.70B |
Dividend Yield | 3.81% | 3.32% |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
Target Corporation (TGT) trades at $138.50, down 0.8% on the day, with a bullish technical outlook supported by moving averages. The company maintains stable revenue near $106.6 billion (2025) and has beaten earnings estimates for three consecutive quarters. Recent news highlights new product collaborations and institutional buying interest, while analyst consensus leans slightly bullish with a $138.21 price target.
Target's investment case balances solid fundamentals against margin pressures. Opportunities include consistent dividend payments and market share gains in retail, but risks involve competitive pressures and potential consumer spending slowdowns. The stock offers value with a P/E of 18.44 but requires monitoring of net income margin trends.
Trailing returns across standard periods
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →